Business6 years ago
Celgene buys cancer therapy maker Impact Biomedicines for $1.1B
Celgene Corp. has announced the acquisition of Impact Biomedicines, a company developing medication to combat bone marrow cancer. Celgene, headquartered in Summit, N.J., will purchase San...